Westlake Village, CA, March 1, 2015 – FlemingMartin, LLC is pleased to announce that KYTHERA Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, has hired Alexander Azoy to be their Corporate Controller.
Mr. Azoy brings over 15 years of Accounting and Finance experience with an industry focus in life sciences, consumer products, technology, and media/entertainment. He has spent the last couple of years as the Director of Business Finance Strategy at Warner Brothers Entertainment Group. Prior to this, Alex was a Senior Manager with Ernst & Young, where he worked for almost a decade. Alex holds a BS in Accounting from California State University, Northridge.
KYTHERA [NASDAQ: KYTH] is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market. Its objective is to develop first-in-class, prescription products using an approach that relies on the scientific rigor of biotechnology to address unmet needs in the rapidly-growing market for aesthetic medicine. Best known for its development of a non-surgical injectable for the treatment of double chins, Kythera is committed to translating rigorous, yet elegant science into products that address much-cited, but under-treated aesthetic complaints.
FlemingMartin, LLC, (www.flemingmartin.com) is a leading retained executive search firm with offices in Northern and Southern California. FlemingMartin partners with Boards and CEOs of companies nationwide to build successful execution-focused management teams. FlemingMartin focuses in the Technology, Manufacturing, Consumer Products & Services, and Energy industries. The Firm’s principals are trusted advisors and business partners who enable companies to gain powerful, far-reaching, and lasting contributions from their executive-level human capital.